Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Aug;61(8):671-7.
doi: 10.1136/thx.2005.052241. Epub 2006 May 2.

Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study

M H Brutsche  1 , S H Downs, C Schindler, M W Gerbase, J Schwartz, M Frey, E W Russi, U Ackermann-Liebrich, P Leuenberger; SAPALDIA Team
Affiliations

Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study

M H Brutsche et al. Thorax. 2006 Aug.

Abstract

Background: Bronchial hyperresponsiveness (BHR) is a common feature of asthma. However, BHR is also present in asymptomatic individuals and its clinical and prognostic significance is unclear. We hypothesised that BHR might play a role in the development of chronic obstructive pulmonary disease (COPD) as well as asthma.

Methods: In 1991 respiratory symptoms and BHR to methacholine were evaluated in 7126 of the 9651 participants in the SAPALDIA cohort study. Eleven years later 5825 of these participants were re-evaluated, of whom 4852 performed spirometric tests. COPD was defined as an FEV1/FVC ratio of <0.70.

Results: In 1991 17% of participants had BHR, of whom 51% were asymptomatic. Eleven years later the prevalence of asthma, wheeze, and shortness of breath in formerly asymptomatic subjects with or without BHR was, respectively, 5.7% v 2.0%, 8.3% v 3.4%, and 19.1% v 11.9% (all p<0.001). Similar differences were observed for chronic cough (5.9% v 2.3%; p = 0.002) and COPD (37.9% v 14.3%; p<0.001). BHR conferred an adjusted odds ratio (OR) of 2.9 (95% CI 1.8 to 4.5) for wheezing at follow up among asymptomatic participants. The adjusted OR for COPD was 4.5 (95% CI 3.3 to 6.0). Silent BHR was associated with a significantly accelerated decline in FEV1 by 12 (5-18), 11 (5-16), and 4 (2-8) ml/year in current smokers, former smokers and never smokers, respectively, at SAPALDIA 2.

Conclusions: BHR is a risk factor for an accelerated decline in FEV1 and the development of asthma and COPD, irrespective of atopic status. Current smokers with BHR have a particularly high loss of FEV1.

PubMed Disclaimer

Conflict of interest statement

Competing interests: none declared.

References

    1. Koskela H O, Hyvarinen L, Brannan J D.et al Responsiveness to three bronchial provocation tests in patients with asthma. Chest 20031242171–2177. - PubMed
    1. Magnussen H, Richter K, Taube C. Are chronic obstructive pulmonary disease (COPD) and asthma different diseases? Clin Exp Allergy 199828(Suppl 5)187–94 2035. - PubMed
    1. Sparrow D, O'Connor G, Colton T.et al The relationship of nonspecific bronchial responsiveness to the occurrence of respiratory symptoms and decreased levels of pulmonary function. The Normative Aging Study. Am Rev Respir Dis 19871351255–1260. - PubMed
    1. Woolcock A J, Peat J K, Salome C M.et al Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population. Thorax 198742361–368. - PMC - PubMed
    1. Burney P G, Britton J R, Chinn S.et al Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax 19874238–44. - PMC - PubMed

Publication types